Search by Drug Name or NDC
NDC 70069-0261-01 Sodium Nitroprusside 25 mg/mL Details
Sodium Nitroprusside 25 mg/mL
Sodium Nitroprusside is a INTRAVENOUS INJECTION, SOLUTION, CONCENTRATE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Somerset Therapeutics, LLC. The primary component is SODIUM NITROPRUSSIDE.
Product Information
| NDC | 70069-0261 |
|---|---|
| Product ID | 70069-261_040ec67b-55ea-41fd-ae73-8d1ef5ca145b |
| Associated GPIs | 36400040102020 |
| GCN Sequence Number | 019652 |
| GCN Sequence Number Description | nitroprusside sodium VIAL 25 MG/ML INTRAVEN |
| HIC3 | A4Y |
| HIC3 Description | ANTIHYPERTENSIVES, MISCELLANEOUS |
| GCN | 01532 |
| HICL Sequence Number | 000136 |
| HICL Sequence Number Description | NITROPRUSSIDE SODIUM |
| Brand/Generic | Generic |
| Proprietary Name | Sodium Nitroprusside |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Sodium Nitroprusside |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION, CONCENTRATE |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 25 |
| Active Ingredient Units | mg/mL |
| Substance Name | SODIUM NITROPRUSSIDE |
| Labeler Name | Somerset Therapeutics, LLC |
| Pharmaceutical Class | Vasodilation [PE], Vasodilator [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA210882 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 70069-0261-01 (70069026101)
| NDC Package Code | 70069-261-01 |
|---|---|
| Billing NDC | 70069026101 |
| Package | 1 VIAL in 1 CARTON (70069-261-01) / 2 mL in 1 VIAL |
| Marketing Start Date | 2018-08-17 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |